StonvexLoading…
StonvexStonvexStonvexCore line items from VNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.08B | $2.98B | $3.10B | $3.18B |
Operating Income | $561.60M | $537.00M | $543.40M | $577.90M |
Net Income | $406.10M | $422.20M | $376.90M | $401.30M |
EPS (Diluted) | $2.76 | $2.75 | $2.42 | $2.49 |
Total Assets | $4.37B | $4.31B | $4.29B | $4.34B |
Total Liabilities | $3.12B | $3.25B | $3.40B | $3.76B |
Cash & Equivalents | $492.20M | $356.40M | $340.90M | $204.50M |
Free Cash Flow OCF − CapEx | $441.10M | $344.80M | $394.90M | $261.20M |
Shares Outstanding | 142.20M | 149.30M | 154.30M | 156.00M |